We read with interest the letter by Corcoy (1) with regards to our recent article in Diabetes (2). In this article, we calculated net reclassification using the approach of Pencina et al. (3). We counted the proportion of undiagnosed diabetic individuals with unadjusted HbA1c ≥6.5% who had a 7-single nucleotide polymorphism (SNP)-adjusted HbA1c <6.5%, and the proportion of nondiabetic individuals with unadjusted HbA1c <6.5% who had a 7-SNP-adjusted HbA1c ≥ 6.5%. The difference between these proportions is called “net reclassification” and in this instance indicates the overall proportion of a population whose diagnostic status would change based on the influence of the seven nonglycemic genetic variants that we identified.

No potential conflicts of interest relevant to this article were reported.

1.
Corcoy
R
Comment on: Soranzo et al. Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways. Diabetes 2010;59:3229–3239 (Letter)
.
Diabetes
2011
;
60
:
e10
. DOI:
2.
Soranzo
N
,
Sanna
S
,
Wheeler
E
, et al
.
Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways
.
Diabetes
2010
;
59
:
3229
3239
3.
Pencina
MJ
,
D'Agostino
RB
 Sr
,
D'Agostino
RB
 Jr
,
Vasan
RS
.
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
.
Stat Med
2008
;
27
:
157
172
;
discussion 207–112